Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Treatment of primary central nervous system lymphoma
Lisa M. DeAngelis,
Adília Hormigo
Research output
:
Contribution to journal
›
Article
›
peer-review
67
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of primary central nervous system lymphoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Primary Central Nervous System Lymphoma (PCNSL)
100%
Radiotherapy
66%
Young Patients
66%
Treatment Choice
66%
Initial Treatment
66%
High Incidence
33%
Corticosteroids
33%
Effective Treatment
33%
Central Nervous System
33%
Neurotoxicity
33%
Chemosensitivity
33%
Highly Sensitive
33%
Older Patients
33%
Newly Diagnosed
33%
Working Diagnosis
33%
Popular
33%
Treatment Modalities
33%
Highly Effective
33%
High-dose Methotrexate (HD-MTX)
33%
Withholding
33%
Disease Control
33%
Systemic Chemotherapy
33%
Rising Incidence
33%
Rare Neoplasm
33%
Chemotherapy Alone
33%
Leptomeninges
33%
Whole Brain Radiotherapy
33%
Non-Hodgkin B-cell Lymphoma
33%
Systemic Lymphoma
33%
Medicine and Dentistry
Primary Central Nervous System Lymphoma
100%
Radiation Therapy
66%
Methotrexate
66%
Disease
33%
Neoplasm
33%
Drug Megadose
33%
Central Nervous System
33%
Chemosensitivity
33%
Neurotoxicity
33%
Whole Brain Radiotherapy
33%
B-Cell Lymphoma
33%
Leptomeninx
33%
Nursing and Health Professions
Primary Central Nervous System Lymphoma
100%
Methotrexate
66%
Radiotherapy
66%
Neoplasm
33%
Drug Megadose
33%
Disease Control
33%
B Cell Lymphoma
33%
Neurotoxicity
33%
Whole Brain Radiotherapy
33%
Neuroscience
Radiation Therapy
100%
Primary Central Nervous System Lymphoma
100%
Methotrexate
66%
Central Nervous System
33%
Neurotoxicity
33%
B Cell
33%
Leptomeninx
33%
Immunology and Microbiology
Central Nervous System
100%
Methotrexate
50%
Drug Megadose
25%
B Cell
25%
Leptomeninx
25%
Chemosensitivity
25%